Dr David Chau.He completed his Ph.d in Hong Kong Polytechnic University and University of Portsmouth, UK.He had research experiance in pathogenic mechanisms of neurodegenerative diseases focusing on Parkinson disease.He also establishes collaborations through his expertise in mitochondria biology, immunology and gene regulation.He had many publications Lascaratos G, Chau KY, Zhu H, Gkotsi D, Kamal D, Gout I, Luthert PJ, Schapira AHV, Garway-Heath DF.2017 Systemic PTEN Akt1 mTOR pathway activity in patients with normal tension glaucoma and ocular hypertension Yang SY, Beavan M, Chau KY, Taanman JW, Schapira AHV. 2017. A Human Neural Crest Stem CellDerived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers.Stem Cell Reports.
His research experience into the pathogenic mechanisms of neurodegenerative diseases focusing on Parkinson’s disease. He also establishes collaborations through his expertise in mitochondria biology, immunology and gene regulation.